Skyepharma is an expert drug delivery company developing oral modified release and inhalation products. With a wide range of patented and proven technologies, and indepth expertise and capabilities Skyepharma helps to make good drugs better.
| Website | http://www.skyepharma.com/ |
| Revenue | $136.6 million |
| Employees | 53 (0 on RocketReach) |
| Founded | 1993 |
| Phone | +44 20 7881 0524 |
| Technologies |
JavaScript
,
HTML
,
PHP
+28 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Discovery Tools (Healthcare), Manufacturing |
| Keywords | Drug Delivery, Pharmaceutical Development, Drug Formulation, Patented Technologies, Inhalation Drug Delivery, Pulmonary Drug Delivery, Controlled Release, Extended Release, Pharmaceutical Technologies, Drug Product Development, Dosage Forms, Delivery Systems, Pharmaceutical Manufacturing, Drug Research, Clinical Development |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck & Co., Inc., Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Amgen +38 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 325412 Companies, NAICS Code 3254 Companies |
Looking for a particular Skye Pharma Plc employee's phone or email?
The Skye Pharma Plc annual revenue was $136.6 million in 2026.
The NAICS codes for Skye Pharma Plc are [32541, 325, 32, 325412, 3254].
The SIC codes for Skye Pharma Plc are [283, 28].